Current Pharmacological Management of Idiopathic Overactive Bladder in Children in the UK: A National Survey of Practice

Children with daytime urinary incontinence secondary to idiopathic overactive bladder (IOAB) commonly present to paediatric urologists following failure of standard urotherapy and/or first-line anticholinergics. Off-label oral medications and intravesical botulinum toxin A (BtA) are being increasingly used for treatment-refractory IOAB, despite the paucity of high-quality evidence and guidelines. Knowledge of contemporary paediatric urologists' practice allows specialists to keep up-to-date with current trends in the management of IOAB in children.
Source: Journal of Pediatric Urology - Category: Urology & Nephrology Authors: Source Type: research